
Cara Therapeutics Investor Relations Material
Latest events

M&A Announcement
Cara Therapeutics

Q1 2025
13 May, 2025

Q4 2024
10 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cara Therapeutics Inc
Access all reports
Cara Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing therapies for pruritus and pain management. The company’s research centers on targeting peripheral kappa opioid receptors to treat itch and pain without central nervous system side effects. Cara Therapeutics serves the healthcare sector through research-driven pharmaceutical innovations. The company is headquartered in Stamford, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
CARA
Country
🇺🇸 United States